Category: Impacting News
CRiSPR Therapeutics Stock is Skyrocketing
CRiSPR Therapeutics Rally For those who wonder why CRiSPR Therapeutics ( CRSP ) is soaring we remind that they should have been expecting this rally and for it to be followed by its two sisters Intellia Therapeutics ( NTLA )...
Read More
July 8, 2020
0
COVID-19 and the Stock Market
COVID-19 and the Stock Market The coronavirus that causes COVID-19 is the topic that swallowed all other topics this week. The virus is spreading to many countries around the world. Some media interpreted the CDC's warnings as being in direct...
Read More
February 27, 2020
0
A New Gene Therapy Series Starts Today with Regenxbio
Beyond the firms that are speeding towards bringing prophylactic vaccines against the COVID-19 infection into the clinic we have to consider the other firms that have been negatively affected by the virus pandemic; we expect them to rebound and surge...
Read More
July 16, 2020
0
Optimism: The Market is Rebounding and Biotech Firms Inspiring News
The Market Soared Being optimistic about the greatness of American scientific capability does not mean underestimating the coronavirus' ability to infect, devastate and threaten human lives. Today the market is rebounding from the fear that caused the stock market to...
Read More
March 2, 2020
0
Fighting COVID-19. See Also: Stocks Gains Following the Market's Rebounding
Treating and Preventing COVID-19 Treating COVID-19, Gilead Sciences With regard to treating patients with COVID-19 we believe the most expected product to be used during this virus' outbreak will be Gilead Sciences’ ( GILD ) product remdesivir . This product...
Read More
March 5, 2020
0
Market Frustration, Volatility and Chaos
Stock Market Fluctuations and Volatility Only history can remind us that what’s going on recently with the stock market is not new. Similar situations have taken place during the terms of every president since Ronald Reagan. Indeed, the same stock...
Read More
March 12, 2020
0
Moderna News. See Also: Regeneron Antibody Cocktail Could Reach the Market in October
SARS-CoV-2 Virus Vaccines Moderna On Monday Moderna ( MRNA ) started its Phase 3 clinical trial on 30,000 people with its product mRNA-1273. Separately, in a press release Moderna announced a preclinical study evaluating its product mRNA-1273 has been published in...
Read More
July 29, 2020
0
A Market in Chaos. Moderna's Human Trial Began Today
A Market in Chaos The Market is in chaos. When this happens the market needs to be stopped from causing massive unwarranted harm to countries' economies, the firms and investors in the stock market. A healthy market does not drop...
Read More
March 16, 2020
0
Compugen: A Stock To Keep
Compugen Compugen ( CGEN ) cancer immunotherapy’s predictive target computational discovery platforms enabled it to identify two checkpoint proteins, PVRIG and TIGIT, when nobody else could. Compugen’s technological capability has also enabled it to create therapeutic inhibitors of its two...
Read More
August 3, 2020
0
Seres Therapeutics Oral Microbiome Product SER-109 Meets Trial Endpoint
Seres Therapeutics Oral Microbiome Product SER-109 for Recurrent C. Difficile Infection Meets Trial Endpoint SER-109 demonstrated a highly statistically significant 30.2% absolute reduction in the rate of C. difficile infection recurrence compared to placebo. Efficacy results Support BLA filing as...
Read More
August 10, 2020
0
Search ProhostBiotech
Popular Links
23andMe Holding Co (ME)Abbott Laboratories (ABT)AbbVie Inc (ABBV)AbCelleraAbeona Therapeutics (ABEO)Ablynx (ABLX)AbVitro IncAcadia (ACAD)Acceleron Pharma (XLRN)AcelRx Pharmaceuticals (ACRX).Acorda Therapeutics Inc (ACOR)Acumen Pharmaceuticals (ABOS)AdaptImmune Therapeutics (ADAP)Adaptive BiotechnologiesADC Therapeutics (ADCT)Adimab LLCAdvanced Micro Devices (AMD)Advaxis (ADXS)Adverum Biotechnologies (ADVM)Aerie Pharmaceuticals (AERI)AgenTus TherapeuticsAgenus (AGEN)AgeX Therapeutics (AGE)Agilent Technologies (A)Agilis Biotherapeutics IncAgios Pharmaceuticals (AGIO)AIM ImmunoTech (AIM)Aimmune Therapeutics (AIMT)Akari Therapeutics (AKTX)Akashi TherapeuticsAkcea Therapeutics (AKCA)Akebia Therapeutics Inc (AKBA)Akero Therapeutics (AKRO)Akous Inc (a wholly owned subsidiary of Eli Lilly Company)Alder BioPharmaceuticals (ALDR)Alexion Pharmaceuticals (ALXN)Alkermes (ALKS)Allergan Plc (AGN)Allogene TherapeuticsAllogene Therapeutics (ALLO)